The miR-17-92 cluster has previously been reported to amplify tumour angiogenesis in in vitro culture and mouse models, by repressing expression of anti-angiogenic proteins including thrombospondin-1 (THBS1) and connective tissue growth factor (CTGF) [79,80]. The gene discussed is THBS1; the disease is neoplasm.